Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$12.16 - $19.42 $1.03 Million - $1.65 Million
-85,000 Reduced 87.09%
12,600 $202,000
Q2 2022

Aug 12, 2022

BUY
$9.99 - $21.35 $26,973 - $57,645
2,700 Added 2.85%
97,600 $1.66 Million
Q1 2022

May 12, 2022

BUY
$14.08 - $27.63 $718,080 - $1.41 Million
51,000 Added 116.17%
94,900 $1.24 Million
Q4 2021

Feb 14, 2022

SELL
$26.55 - $40.57 $204,435 - $312,389
-7,700 Reduced 14.92%
43,900 $593,000
Q3 2021

Nov 10, 2021

BUY
$39.27 - $72.94 $530,145 - $984,690
13,500 Added 35.43%
51,600 $504,000
Q2 2021

Aug 11, 2021

SELL
$31.29 - $56.64 $3,129 - $5,664
-100 Reduced 0.26%
38,100 $195,000
Q1 2021

May 14, 2021

BUY
$39.71 - $90.58 $301,796 - $688,408
7,600 Added 24.84%
38,200 $340,000
Q4 2020

Feb 16, 2021

BUY
$27.07 - $84.35 $414,171 - $1.29 Million
15,300 Added 100.0%
30,600 $131,000
Q3 2020

Nov 13, 2020

SELL
$28.06 - $37.16 $11,224 - $14,863
-400 Reduced 2.55%
15,300 $51,000
Q2 2020

Aug 10, 2020

SELL
$18.5 - $34.34 $3.09 Million - $5.73 Million
-166,800 Reduced 91.4%
15,700 $50,000
Q4 2019

Feb 11, 2020

BUY
$19.49 - $32.63 $662,660 - $1.11 Million
34,000 Added 22.9%
182,500 $51,000
Q3 2019

Nov 12, 2019

SELL
$22.49 - $26.81 $4,498 - $5,362
-200 Reduced 0.13%
148,500 $37,000
Q2 2019

Aug 14, 2019

BUY
$20.48 - $27.76 $270,336 - $366,432
13,200 Added 9.74%
148,700 $69,000
Q1 2019

May 10, 2019

BUY
$19.43 - $26.41 $2.63 Million - $3.58 Million
135,500 New
135,500 $93,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $94.9M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.